CIRRUS TABLETS
GlaxoSmithKline UK
Revision date : 2019-12-10
Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
General Information
Revision date
2019-12-10
Product name
CIRRUS TABLETS
Product Synonyms
CIRRUS 5MG/120MG PROLONGED-RELEASE TABLETS * ZYRTEC-D * ZIRTEK PLUS
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
Company name
GlaxoSmithKline UK
E-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
Section 2
EU Classification
Directive 67/548/EEC or 1999/45/EC as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device. Regulation (EC) No 1272/2008 as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended Exempt from requirements - product regulated as a medicinal product, cosmetic product or medical device.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
